Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 58408-58409 [2010-24006]
Download as PDF
58408
Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices
unless the Part D appeals rules provide
otherwise, the Part C appeals rules
(including the annually adjusted AIC
threshold amount) apply to Part D
appeals to the extent they are
appropriate. More specifically,
§ 423.1970 and § 423.1976 of the Part D
appeals rules discuss the AIC threshold
amounts for ALJ hearings and judicial
review. Section 423.1970(a) grants a Part
D enrollee, who is dissatisfied with the
Independent Review Entity (IRE)
reconsideration determination, a right to
an ALJ hearing if the amount remaining
in controversy after the IRE
reconsideration meets the threshold
amount established annually by the
Secretary. Sections 423.1976(a) and (b)
allow a Part D enrollee to request
judicial review of an ALJ or MAC
decision if, in part, the AIC meets the
threshold amount established annually
by the Secretary.
II. Annual AIC Adjustments
A. AIC Adjustment Formula and AIC
Adjustments
As previously noted, section 940 of
the MMA requires that the AIC
threshold amounts be adjusted
annually, beginning in January 2005, by
the percentage increase in the medical
care component of the consumer price
index (CPI) for all urban consumers
(U.S. city average) for July 2003 to the
July of the preceding year involved and
rounded to the nearest multiple of $10.
B. Calendar Year 2011
The AIC threshold amount for ALJ
hearing requests will remain at $130
and the AIC threshold amount for
judicial review will rise to $1,300 for
the 2011 calendar year. These updated
amounts are based on the 30.34 percent
increase in the medical care component
of the CPI from July of 2003 to July of
2010. The CPI level was at 297.6 in July
of 2003 and rose to 387.898 in July of
2010. This change accounted for the
30.34 percent increase. The AIC
threshold amount for ALJ hearing
requests changes to $130.34 based on
the 30.34 percent increase. In
accordance with section 940 of the
MMA, this amount is rounded to the
nearest multiple of $10. Therefore, the
2011 AIC threshold amount for ALJ
hearings is $130. The AIC threshold
amount for judicial review changes to
$1,303.42 based on the 30.34 percent
increase. This amount was rounded to
the nearest multiple of $10, resulting in
a 2011 AIC threshold amount of $1,300.
C. Summary Table of Adjustments in
the AIC Threshold Amounts
In Table 1 below, we list the (CY)
2005 through 2011 threshold amounts.
TABLE 1—AMOUNT-IN-CONTROVERSY THRESHOLD AMOUNTS
CY 2005
CY 2006
CY 2007
CY 2008
CY 2009
CY 2010
CY 2011
$100
1,050
$110
1,090
$110
1,130
$120
1,180
$120
1,220
$130
1,260
$130
1,300
ALJ Hearing .........................................................................
Judicial Review ....................................................................
* CY—Calendar Year.
III. Collection of Information
Requirements
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
Centers for Disease Control and
Prevention
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m.,
October 13, 2010.
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018. Telephone (859) 334–4611, Fax
(859) 334–4619.
Status: Open to the public, but
without a public comment period. To
access by conference call, dial the
following information: (866) 659–0537,
Participant Pass Code 9933701.
Background: The ABRWH was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
compensation program. Key functions of
Dated: September 2, 2010.
Donald M. Berwick,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2010–23584 Filed 9–23–10; 8:45 am]
srobinson on DSKHWCL6B1PROD with NOTICES
BILLING CODE 4120–01–P
VerDate Mar<15>2010
16:12 Sep 23, 2010
Jkt 220001
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
the ABRWH include providing advice
on the development of probability of
causation guidelines that have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule;
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2011.
Purpose: The ABRWH is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
E:\FR\FM\24SEN1.SGM
24SEN1
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. The Subcommittee on
Procedures Review was established to
aid the ABRWH in carrying out its duty
to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on
Procedures Review is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes:
Review of draft prototype documents for
informing the public on completed
Subcommittee procedure reviews;
discussion of the following ORAU &
OCAS procedures: PER–012
(‘‘Evaluation of Highly Insoluble
Plutonium Compounds’’), PER–009
(‘‘Target Organs for Lymphoma’’), OCAS
TIB–0013 (‘‘Special External Dose
Reconstruction Considerations for
Mallinckrodt Workers’’), OTIB–014
(‘‘Rocky Flats Internal Dosimetry CoWorker Extension’’), OTIB–019
(‘‘Analysis of Co-worker Bioassay Data
for Internal Dose Assignment’’), OTIB–
0029 (‘‘Internal Dosimetry Co-worker
Data for Y–12’’), OTIB–0049
(‘‘Estimating Doses for Plutonium
Strongly Retained in the Lung’’), OTIB–
0047 (External Radiation Monitoring at
the Y–12 Facility During the 1948–1949
Period’’), OTIB–0051 (‘‘Effect of
Threshold Energy and Angular
Response of NTA Film on Missed
Neutron Dose at the Oak Ridge Y–12
Facility’’), OTIB–0052 (‘‘Parameters to
Consider When Processing Claims for
Construction Trade Workers’’), OTIB–
0054 (‘‘Fission and Activation Product
Assignment for Internal Dose-Related
Gross Beta and Gross Gamma
Analyses’’), OTIB–0057 (‘‘External
Radiation Dose Estimates For
Individuals Near the 1958 Criticality
Accident at the Oak Ridge Y–12 Plant’’),
OTIB–0070 (‘‘Dose Reconstruction
During Residual Radioactivity Periods at
Atomic Weapons Employer Facilities’’),
and TBD 6000 (‘‘Site Profile for Atomic
Weapons Employers that Worked
Uranium and Thorium Metals’’); and a
continuation of the comment-resolution
process for other dose reconstruction
procedures under review by the
Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public,
but without a public comment period.
In the event an individual wishes to
VerDate Mar<15>2010
16:12 Sep 23, 2010
Jkt 220001
provide comments, written comments
may be submitted. Any written
comments received will be provided at
the meeting and should be submitted to
the contact person below in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll
Free 1 (800) CDC–INFO, E-mail
dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: September 17, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
58409
Blvd., Rm. 676, Bethesda, MD 20892–4878,
301–594–4861, mooremar@nidcr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; RFA DE–11–001
Collaborative Research on the Transition
From Acute to Chronic Pain: New Models
and Measures in Clinical and Preclinical Pain
Research (R01).
Date: October 28, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, 8777 Georgia Avenue,
Silver Spring, MD 20910.
Contact Person: Victor Henriquez, PhD,
Scientific Review Officer, DEA/SRB/NIDCR,
6701 Democracy Blvd., Room 668, Bethesda,
MD 20892–4878, 301–451–2405,
henriquv@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
[FR Doc. 2010–24006 Filed 9–23–10; 8:45 am]
Dated: September 20, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4163–18–P
[FR Doc. 2010–23951 Filed 9–23–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Scientific Review of P01
Applications submitted to PAR 08–117.
Date: October 20, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Marilyn Moore-Hoon, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, 6701 Democracy
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review F30s, R03.
Date: October 18, 2010.
Time: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Mary Kelly, Scientific
Review Officer, Scientific Review Branch,
E:\FR\FM\24SEN1.SGM
24SEN1
Agencies
[Federal Register Volume 75, Number 185 (Friday, September 24, 2010)]
[Notices]
[Pages 58408-58409]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24006]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Review, Advisory Board on Radiation
and Worker Health (ABRWH), National Institute for Occupational Safety
and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
subcommittee:
Time and Date: 9 a.m.-5 p.m., October 13, 2010.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a public comment period. To
access by conference call, dial the following information: (866) 659-
0537, Participant Pass Code 9933701.
Background: The ABRWH was established under the Energy Employees
Occupational Illness Compensation Program Act of 2000 to advise the
President on a variety of policy and technical functions required to
implement and effectively manage the compensation program. Key
functions of the ABRWH include providing advice on the development of
probability of causation guidelines that have been promulgated by the
Department of Health and Human Services (HHS) as a final rule; advice
on methods of dose reconstruction which have also been promulgated by
HHS as a final rule; advice on the scientific validity and quality of
dose estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes of
workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the ABRWH to HHS, which subsequently
delegated this authority to CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August 3, 2001, renewed at
appropriate intervals, and will expire on August 3, 2011.
Purpose: The ABRWH is charged with (a) providing advice to the
Secretary, HHS, on the development of guidelines under Executive Order
13179; (b) providing advice to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction efforts performed for this
program; and (c) upon request by the Secretary, HHS, advising the
Secretary on whether there is a class of employees at any Department of
Energy facility who were exposed to radiation
[[Page 58409]]
but for whom it is not feasible to estimate their radiation dose, and
on whether there is a reasonable likelihood that such radiation doses
may have endangered the health of members of this class. The
Subcommittee on Procedures Review was established to aid the ABRWH in
carrying out its duty to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on Procedures Review is responsible
for overseeing, tracking, and participating in the reviews of all
procedures used in the dose reconstruction process by the NIOSH
Division of Compensation Analysis and Support (DCAS) and its dose
reconstruction contractor.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: Review of draft prototype documents for informing the public
on completed Subcommittee procedure reviews; discussion of the
following ORAU & OCAS procedures: PER-012 (``Evaluation of Highly
Insoluble Plutonium Compounds''), PER-009 (``Target Organs for
Lymphoma''), OCAS TIB-0013 (``Special External Dose Reconstruction
Considerations for Mallinckrodt Workers''), OTIB-014 (``Rocky Flats
Internal Dosimetry Co-Worker Extension''), OTIB-019 (``Analysis of Co-
worker Bioassay Data for Internal Dose Assignment''), OTIB-0029
(``Internal Dosimetry Co-worker Data for Y-12''), OTIB-0049
(``Estimating Doses for Plutonium Strongly Retained in the Lung''),
OTIB-0047 (External Radiation Monitoring at the Y-12 Facility During
the 1948-1949 Period''), OTIB-0051 (``Effect of Threshold Energy and
Angular Response of NTA Film on Missed Neutron Dose at the Oak Ridge Y-
12 Facility''), OTIB-0052 (``Parameters to Consider When Processing
Claims for Construction Trade Workers''), OTIB-0054 (``Fission and
Activation Product Assignment for Internal Dose-Related Gross Beta and
Gross Gamma Analyses''), OTIB-0057 (``External Radiation Dose Estimates
For Individuals Near the 1958 Criticality Accident at the Oak Ridge Y-
12 Plant''), OTIB-0070 (``Dose Reconstruction During Residual
Radioactivity Periods at Atomic Weapons Employer Facilities''), and TBD
6000 (``Site Profile for Atomic Weapons Employers that Worked Uranium
and Thorium Metals''); and a continuation of the comment-resolution
process for other dose reconstruction procedures under review by the
Subcommittee.
The agenda is subject to change as priorities dictate.
This meeting is open to the public, but without a public comment
period. In the event an individual wishes to provide comments, written
comments may be submitted. Any written comments received will be
provided at the meeting and should be submitted to the contact person
below in advance of the meeting.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-
mail dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: September 17, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-24006 Filed 9-23-10; 8:45 am]
BILLING CODE 4163-18-P